Login
$GS
$893.28 +$17.60 (2.01%) Close

Consolidated Balance Sheets

In millions of USD, except per-share amounts
Q2 FY2026
As of Jun 30, 2026
Q1 FY2026
As of Mar 31, 2026
Q4 FY2025
As of Dec 31, 2025
Q3 FY2025
As of Sep 30, 2025
Q2 FY2025
As of Jun 30, 2025
Q1 FY2025
As of Mar 31, 2025
Q4 FY2024
As of Dec 31, 2024
Q3 FY2024
As of Sep 30, 2024
Q2 FY2024
As of Jun 30, 2024
Q1 FY2024
As of Mar 31, 2024
Q4 FY2023
As of Dec 31, 2023
Q3 FY2023
As of Sep 30, 2023
Q2 FY2023
As of Jun 30, 2023
Q1 FY2023
As of Mar 31, 2023
Q4 FY2022
As of Dec 31, 2022
Q3 FY2022
As of Sep 30, 2022
Q2 FY2022
As of Jun 30, 2022
Q1 FY2022
As of Mar 31, 2022
Q4 FY2021
As of Dec 31, 2021
Q3 FY2021
As of Sep 30, 2021
Assets
Cash and cash equivalents
Collateralized agreements
Securities purchased under agreements to resell (includes $121,206 and $126,007 at fair value)
Securities borrowed (includes $61,756 and $51,581 at fair value)
Customer and other receivables (includes $292 and $315 at fair value)
Trading assets (at fair value and includes $97,406 and $40,143 pledged as collateral)
Trading assets (at fair value and includes $185,318 and $158,641 pledged as collateral)
Investments (includes $103,509 and $75,767 at fair value)
Investments:
Available-for-sale securities (at fair value; amortized cost of $156,636 and $99,116)
Held-to-maturity securities
Other investments (includes $24,343 and $24,938 at fair value)
Loans (net of allowance of $2,188 and $2,148, and includes $4,640 and $4,905 at fair value)
Other assets (includes $202 and $180 at fair value)
Total assets
Liabilities and shareholders’ equity
Deposits (includes $90,249 and $76,569 at fair value)
Collateralized financings
Securities sold under agreements to repurchase (at fair value)
Securities loaned (includes $12,871 and $11,995 at fair value)
Other secured financings (includes $34,865 and $27,833 at fair value)
Customer and other payables
Trading liabilities (at fair value)
Unsecured short-term borrowings
Unsecured long-term borrowings (includes $144,703 and $112,683 at fair value)
Other liabilities (includes $264 and $111 at fair value)
Total liabilities
Shareholders’ equity
Preferred stock; aggregate liquidation preference of $13,028 and $15,153
Common stock; 936,341,620 and 931,995,446 shares issued, and 291,442,355 and 296,476,742 shares outstanding
Share-based awards
Nonvoting common stock; no shares issued and outstanding
Additional paid-in capital
Retained earnings
Accumulated other comprehensive loss
Stock held in treasury, at cost; 644,899,267 and 635,518,706 shares
Total shareholders’ equity
Total liabilities and shareholders’ equity

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support